Clinical Trial Update: Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) [Phase 2]

View source ↗

Summary

Phase II study evaluating postoperative concurrent chemoradiotherapy for esophageal squamous cell carcinoma (ESO-Shanghai 17) is active but not currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Esophagus Cancer

Snippet

Sponsor: Fudan University | Conditions: Esophagus Cancer, Esophageal Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING